跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVEXIBAM 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EVEXIBAM 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Approved
STANDARD
EVEXIBAM 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Intas Third Party Sales 2005 S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 16, 2022
Approval ID
cb3bb4b58de77174
Company
Intas Third Party Sales 2005 S.L.
Type
Standard
Approval Details
Approval Id
cb3bb4b58de77174
Drug Cima Aemps Name
EVEXIBAM 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number
86629
Holder Company Name
Intas Third Party Sales 2005 S.L.
Marketing Company Name
Intas Third Party Sales 2005 S.L.
Authorization Date
2022-03-16
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
250 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Intas Third Party Sales 2005 S.L.
Active Ingredients
LEVETIRACETAM
250 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 16, 2022
Approval ID
cb3bb4b58de77174
Type
Standard
Back to CIMA-AEMPS Approvals